Celiac disease markers in patients with liver diseases: A single center large scale screening study

Table 2 Immunoglobulin A anti-tissue transglutaminase seropositivity in patients with liver disease and patients who underwent liver transplantation

IgA anti-tTG seropositivity	Diagnosis	M/F	n (%)
Liver disease	Wilson’s disease	1/3	4 (12.9)
	Autoimmune hepatitis type I	1/4	5 (6.5)
	Primary biliary cirrhosis	0/1	1 (3.1)
	Budd-Chiari syndrome	0/1	1 (7.1)
	Mild hepatic liver tests abnormalities	5/2	7 (20)
	Liver steatosis	3/1	4 (3.3)
	Viral hepatitis B	1/0	1 (0.9)
	Toxic hepatitis	1/0	1 (4.8)
	Nonalcoholic steatohepatitis	0/2	2 (8.7)
	Primary sclerosing cholangitis	1/1	2 (3.4)
	Polycystic liver	0/1	1 (10)
OLTx	Wilson’s disease	1/1	2 (6.9)
	Autoimmune hepatitis type I	0/2	2 (6.1)
	Alcoholic liver cirrhosis	1/0	1 (0.6)

IgA: Immunoglobulin A; tTG: Tissue transglutaminase; OLTx: Patients who underwent liver transplantation; M/F: Male/female.